Currently, patients with clinically isolated syndrome (CIS) and brain lesions on MRI suggestive of multiple sclerosis (MS), are ... with CIS and at least three T2-weighted hyperintense brain ...

Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, ...

Better guidelines related to undesirable disease activity seen on MRI will need to be developed ... Relapsing–remitting multiple sclerosis. BPF: Brain parenchymal fraction; CIS: Clinically ...

Using an animal model of multiple sclerosis (MS), researchers at ... Disorders and Stroke (NINDS), combined repeated MRI imaging with brain-tissue analysis, including gene expression, to track ...

reduces the rate of relapse in patients with multiple sclerosis (MS); however, it is unknown whether this therapy also inhibits the development of new lesions. Massacesi et al. used MRI to ...